Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 7, 2017

Primary Completion Date

January 11, 2019

Study Completion Date

January 11, 2019

Conditions

Bladder Cancer

Interventions

DRUG

Fluorine F 18 Ara-G

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/MR imaging

PROCEDURE

Magnetic Resonance Imaging

Undergo PET/MR imaging

Trial Locations (1)

University of California, San Francisco, San Francisco